Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children
The aims of this study were to evaluate the incidence of invasive pneumococcal disease (IPD) in Italian children and perform serotyping by PCR-based assays directly on clinical samples. A 1-year paediatric (0–14 years) population-based surveillance study was designed to evaluate the incidence of IPD in the province of Florence, Italy, by cultural and molecular methods. Among 92 children (80 with pneumonia, 8 with meningitis/sepsis, 4 with arthritis), 4 cases of IPD were diagnosed both by culture and real-time PCR and 18 cases exclusively by molecular methods. The sensitivity of molecular methods was significantly higher than that of cultural methods (Cohen’s κ 0.41; McNemar P=0.000008). The incidence of IPD in children below 2 years of age was 11.5/100 000 and 51.8/100 000 by cultural and molecular methods, respectively. Pneumococcal serotyping by multiplex sequential PCR was obtained in 19/22 samples. Real-time PCR and multiplex sequential PCR can be used directly on biological samples, improving the ability to diagnose IPD. The incidence of IPD appears 5–10 times higher by PCR than by cultural methods.
BlackS.,
ShinefieldH.,
BaxterR.,
AustrianR.,
BrackenL.,
HansenJ.,
LewisE.,
FiremanB.2004; Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J 23:485–489[CrossRef]
BlackS.,
ShinefieldH.,
EskolaJ.,
WhitneyC.2007; Pneumococcal conjugate vaccine. In Vaccines , V edn, chapter 23. Edited by
PlotkinS. A.,
OrensteinW. A.,
OffitP.
Philadelphia, PA: WB Saunders;
ClarkeS. C.2006; Detection of Neisseria meningitidis , Streptococcus pneumoniae , and Haemophilus influenzae in blood and cerebrospinal fluid using fluorescence-based PCR. Methods Mol Biol 345:69–77
CorlessC. E.,
GuiverM.,
BorrowR.,
Edwards-JonesV.,
FoxA. J.,
KaczmarskiE. B.2001; Simultaneous detection of Neisseria meningitidis , Haemophilus influenzae , and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol 39:1553–1558[CrossRef]
EspositoS.,
BosisS.,
ColomboR.,
CarlucciP.,
FaelliN.,
FossaliE.,
PrincipiN.2004; Evaluation of rapid assay for detection of Streptococcus pneumoniae urinary antigen among infants and young children with possibile invasive pneumococcal disease. Pediatr Infect Dis J 23:365–367[CrossRef]
HausdorffW. P.,
BryantJ.,
ParadisoP. R.,
SiberG. R.2000; Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 30:100–121[CrossRef]
KaltoftH.,
ZeuthenN.,
KonradsenH. B.2000; Epidemiology of invasive pneumococcal infections in children aged 0–6 years in Denmark: a 19-year nationwide surveillance study. Acta Paediatr Suppl 89:3–10[CrossRef]
KaplanS. L.,
MasonE. O.Jr,
WaldE. R.,
SchutzeG. E.,
BradleyJ. S.,
TanT. Q.,
HoffmanJ. A.,
GivnerL. B.,
YogevR.,
BarsonW. J.2004; Decrease of invasive pneumococcal infections in children among 8 children’s hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 113:443–449[CrossRef]
McAvinJ. C.,
ReillyP. A.,
RoudabushR. M.,
BarnesW. J.,
SalmenA.,
JacksonG. W.,
BeningaK. K.,
AstorgaA.,
McCleskeyF. K.other authors2001; Sensitive and specific method for rapid identification of Streptococcus pneumoniae using real-time fluorescence PCR. J Clin Microbiol 39:3446–3451[CrossRef]
MorrisonK. E.,
LakeD.,
CrookJ.,
CarloneG. M.,
AdesE.,
FacklamR.,
SampsonJ. S.2000; Confirmation of psaA in all 90 serotypes of Streptococcus pneumoniae by PCR and potential of this assay for identification and diagnosis. J Clin Microbiol 38:434–437
O’HalloranD. M.,
CafferkeyM. T.2005; Multiplex PCR for identification of seven Streptococcus pneumoniae serotypes targeted by a 7-valent conjugate vaccine. J Clin Microbiol 43:3487–3490[CrossRef]
PaiR.,
LimorJ.,
BeallB.2005; Use of pyrosequencing to differentiate Streptococcus pneumoniae serotypes 6A and 6B. J Clin Microbiol 43:4820–4822[CrossRef]
PebodyR. G.,
HellenbrandW.,
D’AnconaF.,
RuutuP. European Union funded Pnc-EURO contributing group; 2006; Pneumococcal disease surveillance in Europe. Euro Surveill 11:171–178
SmithM. D.,
StuartJ.,
AndrewsN. J.,
Telfer BruntonW. A.,
CartwrightK. A.1998; Invasive pneumococcal infection in South and West England. Epidemiol Infect 120:117–123[CrossRef]
VakevainenM.,
EklundC.,
EskolaJ.,
KayhtyH.2001; Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae , evoked by pneumococcal conjugate vaccines, in infants. J Infect Dis 184:789–793[CrossRef]
Van GastelE.,
BruynseelsP.,
VerstrepenW.,
MertensA.2007; Evaluation of a real-time polymerase chain reaction assay for the diagnosis of pneumococcal and meningococcal meningitis in a tertiary care hospital. Eur J Clin Microbiol Infect Dis 26:651–653[CrossRef]
VerhelstR.,
KaijalainenT.,
De BaereT.,
VerschraegenG.,
ClaeysG.,
Van SimaeyL.,
De GanckC.,
VaneechoutteM.2003; Comparison of five genotypic techniques for identification of optochin-resistant pneumococcus-like isolates. J Clin Microbiol 41:3521–3525[CrossRef]
von KriesR.,
SiedlerA.,
SchmittH. J.,
ReinertR. R.2000; Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin Infect Dis 31:482–487[CrossRef]
WhitneyC. G.,
FarleyM. M.,
HadlerJ.,
HarrisonL. H.,
BennettN. M.,
LynfieldR.,
ReingoldA.,
CieslakP. R.,
PilishviliT.other authors2003; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein polysaccharide conjugate vaccine. N Engl J Med 348:1737–1746[CrossRef]
Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children